Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans. (Q30382436)

21 June 2017

Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans. (English)

1 reference

21 June 2017

0 references

1 reference

X Huang

1

1 reference

PubMed ID

26662574

21 June 2017

Z Yang

series ordinal

2

1 reference

21 June 2017

12 December 2015

1 reference

Journal of Endocrinological Investigation

21 June 2017

1 reference

21 June 2017

39

1 reference

21 June 2017

6

1 reference

21 June 2017

607-615

1 reference

https://scigraph.springernature.com/pub.10.1007/s40618-015-0408-2

21 June 2017

0 references

cites work

Evaluating the validity of animal models for research into therapies for immune-based disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Human resistin and the RELM of Inflammation in diabesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Correlation between serum resistin level and adiposity in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Regulation of fasted blood glucose by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Weight cycling enhances adipose tissue inflammatory responses in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Central resistin overexposure induces insulin resistance through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Modulation of resistin expression by retinoic acid and vitamin A status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

The value of animal models for drug development in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Effects of alternate-day fasting on high-fat diet-induced insulin resistance in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

The origins and drivers of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Role of resistin in obesity, insulin resistance and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipokines mediate inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin- and Obesity-associated metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

An inflammatory cascade leading to hyperresistinemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipokines and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

The forkhead transcription factor FOXO1 stimulates the expression of the adipocyte resistin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin concentration and gestational diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Re-evaluating the general(ized) roles of AMPK in cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin, central obesity, and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin is expressed in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin expression and regulation in mouse pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Hypothalamic resistin induces hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Role of resistin in diet-induced hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Serum resistin levels are associated with adiposity and insulin sensitivity in obese Hispanic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin expression in human granulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Plasma resistin is associated with single nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the general Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin in rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin increases platelet P-selectin levels via p38 MAPK signal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipose tissue and its role in organ crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Human resistin inhibits myogenic differentiation and induces insulin resistance in myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Central resistin induces hepatic insulin resistance via neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Murine models to evaluate novel and conventional therapeutic strategies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Endothelin-1 stimulates resistin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin competes with lipopolysaccharide for binding to toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Fat and beyond: the diverse biology of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Central administration of resistin promotes short-term satiety in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0408-2

Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study

21 January 2018

1 reference

12 December 2020

Resistin levels in morbid obese patients following the biliopancreatic diversion surgery

1 reference

12 December 2020

Decreased Resistin Expression in Mice with Different Sensitivities to a High-Fat Diet

1 reference

12 December 2020

Acute and sustained inflammation and metabolic dysfunction induced by high refined carbohydrate-containing diet in mice.

1 reference

12 December 2020

Serum resistin concentrations are higher in human obesity but independent from insulin resistance

1 reference

12 December 2020

Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia

1 reference

12 December 2020

Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans.

1 reference

12 December 2020

The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure

1 reference

12 December 2020

Human resistin: found in translation from mouse to man

1 reference

12 December 2020

10.1007/S40618-015-0408-2

Identifiers

DOI

1 reference

PubMed ID

26662574

Dimensions Publication ID

21 June 2017

0 references

1 reference

PubMed ID

26662574